Schedule 13D ownership disclosure
G1 THERAPEUTICS INC
Security class unavailable · CUSIP: 3621LQ109
Event date: 2022-11-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.1300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-24-041509
- Form type
- SC 13D
- Filer
- ESHELMAN FREDRIC N
- CIK
- CIK 1033409
- Filed
- Feb 21, 2024
- Reporting period
- Nov 18, 2022
- Description
- Schedule 13D beneficial ownership